Cargando…
Single subanesthetic dose of ketamine produces delayed impact on brain [(18)F]FDG PET imaging and metabolic connectivity in rats
INTRODUCTION: Ketamine, a glutamate NMDA receptor antagonist, is suggested to act very rapidly and durably on the depressive symptoms including treatment-resistant patients but its mechanisms of action remain unclear. There is a requirement for non-invasive biomarkers, such as imaging techniques, wh...
Autores principales: | Chaib, Sarah, Bouillot, Caroline, Bouvard, Sandrine, Vidal, Benjamin, Zimmer, Luc, Levigoureux, Elise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372660/ https://www.ncbi.nlm.nih.gov/pubmed/37521685 http://dx.doi.org/10.3389/fnins.2023.1213941 |
Ejemplares similares
-
Multimodal imaging study of the 5-HT(1A) receptor biased agonist, NLX-112, in a model of L-DOPA-induced dyskinesia
por: Chaib, Sarah, et al.
Publicado: (2023) -
Resurfacing of ketamine: The subanesthetic paradigm
por: Ramachandran, Rashmi, et al.
Publicado: (2016) -
Enhanced Fear Memories and Altered Brain Glucose Metabolism ((18)F-FDG-PET) following Subanesthetic Intravenous Ketamine Infusion in Female Sprague–Dawley Rats
por: Radford, Kennett D., et al.
Publicado: (2022) -
A Multi-Atlas Based Method for Automated Anatomical Rat Brain MRI Segmentation and Extraction of PET Activity
por: Lancelot, Sophie, et al.
Publicado: (2014) -
Resting-state brain functional connectivity in patients with chronic pain who responded to subanesthetic-dose ketamine
por: Motoyama, Yasushi, et al.
Publicado: (2019)